A tiny single-celled alga called Chlamydomonas has led to a Nobel Prize. Three scientists who figured out how to control brain cells with light have won the 2026 Nobel Prize in Physiology or Medicine. The award recognizes their work on light-gated ion channels and optogenetics, a technique that has already helped researchers activate memories and is opening new possibilities for restoring vision and treating brain disorders.
How a Single Protein Became a Switch
Peter Hegemann at Humboldt University of Berlin and Georg Nagel at the University of Würzburg wanted to understand how Chlamydomonas senses light. Light-sensing is not unique to animals with eyes. Organisms throughout the living world use light to detect their surroundings and respond to changes in their environment. Even single-cell organisms have proteins that respond to light, using them to move toward or away from light, to generate energy and to respond to the demands of a 24-hour day.
Hegemann and Nagel discovered that Chlamydomonas relies on a single protein called channelrhodopsin. The protein sits in the outer membrane of the algal cell, with part facing the water outside and part facing the inside. It contains a small molecule called retinaldehyde, which absorbs light. When light hits the retinaldehyde, it changes shape, and the channelrhodopsin protein changes shape too. That change opens a tiny passage through the cell membrane. Positively charged particles, including sodium, then flow from the water outside the alga into the cell. This movement of charged particles sends a signal inside the alga that helps it swim.
From Algae to Brain Cells
Solving such a biological question was fascinating, but why a Nobel Prize in physiology or medicine? The answer lies in how nerve cells work. Nerve cells use the movement of charged particles, called ions, across their membranes to control their activity. When positively charged particles flow into a nerve cell, they can make it more active. The researchers realized that if they could put channelrhodopsin into nerve cells, they might be able to switch those cells on simply by shining a light on them.
That is exactly what Hegemann, Nagel and the third winner, Karl Deisseroth, a psychiatrist and bioengineer at Stanford University in California, went on to do. The ability to control nerve cells with light is called optogenetics. It has become a powerful research tool because scientists can use it to switch specific groups of nerve cells on and off and see what happens. First, scientists deliver the gene for channelrhodopsin to the nerve cells they want to study. The gene is usually carried into the cells by a virus that has been altered so that it cannot cause disease. The cells then make the protein, and light can be used to activate them.
The prize honors research that began with a question about how a microscopic alga detects light and grew into a method for switching brain cells on and off. Optogenetics has already helped researchers activate memories, and it is opening new possibilities for restoring vision and treating brain disorders.
